
⸺ Synova Research
Pentadecapeptide derived from a protective protein in gastric juice, studied for gut-lining repair, soft-tissue recovery and inflammation research.
Size
Website checkout coming soon — for now, orders are placed directly via our Telegram. Fast replies & secure payment links.
Independently tested
COA on request
Next-day UK dispatch
Order before 2pm
Research use only
Not for human consumption
⸺ Important
⸺ Overview
BPC-157 is a synthetic peptide based on a sequence found in human gastric juice. Researchers investigate its role in protecting and repairing tissues — including the gut lining, tendons, ligaments and muscle — and its influence on local inflammation and angiogenesis in preclinical models.
⸺ Mechanism of Action
BPC-157 appears to influence growth-factor expression, nitric-oxide signalling and angiogenic pathways involved in tissue repair. In animal studies, this translates to faster healing of soft-tissue and gastrointestinal lesions, alongside protective effects against various forms of induced injury.
⸺ Research
Animal models show protective and reparative effects on gastric and intestinal lining under stress and chemical injury.
Rodent studies describe improved tendon-to-bone healing and ligament repair following BPC-157 administration.
Preclinical work has documented reduced inflammatory markers and enhanced microvascular formation at injury sites.
Summarised from preclinical literature for informational purposes only. Not medical or veterinary advice. Synova Research products are sold strictly for in-vitro and laboratory research.
⸺ Details

Investigational triple receptor agonist targeting GLP-1, GIP and glucagon — studied in animal models for appetite control, energy expenditure and glucose balance.

Dual GLP-1 and GIP receptor agonist studied in preclinical models for glucose regulation, insulin sensitivity and energy balance.

Synthetic analogue of the GLP-1 hormone used in research to study glucose regulation, insulin secretion and the incretin response.